Email ID
Password
Sign me in automatically next time
Maxygen to transfer key assets to new Astellas joint venture
02 July 2009
Ian Haydock

ian.haydock@informa.com

Astellas and Maxygen have agreed to set up a joint venture for the discovery and development of multiple protein-based therapeutic candidates.

The deal builds on the two firms' 2008 alliance for Maxygen's preclinical stage MAXY-4 project, for which Astellas agreed to pay $10 million up...



Please Login to read the full article.
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK Promote your vacancy here
© 2012 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36